FIGURE

Fig. 3

ID

ZDB-FIG-220927-42

Publication

Saronni et al., 2022 - Preclinical Evaluation of Novel Tyrosine-Kinase Inhibitors in Medullary Thyroid Cancer

Other Figures

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

All Figure Page

Back to All Figure Page

Fig. 3

Cell cycle analysis after 6 days of incubation with SU5402, sulfatinib (SULF) and SPP86 in TT (a) and MZ-CRC-1 (b) cell lines. Cells were detected by FACS analysis after staining with propidium iodide. CTR values have been set to 100%. Values represent the mean ± standard error of the mean of at least 3 independent experiments. *: p < 0.05, ***: p < 0.001, CTR: control, SULF: sulfatinib.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Cancers